PepsiCo to pay $1.2 billion to buy Siete, to boost multicultural food offering

Date:

October 1, 2024

PepsiCo’s stock rose Tuesday, bucking the selloff in the broader stock market, after the beverage and snacks giant announced an agreement to buy Mexican-American foods maker Siete Foods for $1.2 billion a week before earnings are released.

Source link

Your Horoscope for October: A Month of Breakthroughs and Unexpected Shifts

Box Office Bomb: Netflix Cancellations Explode After Co-Founder Gives Huge Donation to Kamala

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

PepsiCo to pay $1.2 billion to buy Siete, to boost multicultural food offering

Recent posts

Intuit stock rises on upbeat full-year forecast amid a pivot toward AI

Why solar is the fastest-growing source of U.S. electricity

Cava’s stock slides 8% after CEO and other insiders announce stock sales

PepsiCo probably raised its prices too much, and now it’ll have to pay, analyst says

Commodity markets fear a repeat of China’s 2015 economic slowdown

Perrigo voluntarily recalls 16,500 cans of baby formula because of excessive levels of vitamin D

A weak jobs report couldn’t stop 10-year Treasury yields from rising

Harley-Davidson’s stock down 2% as lowered guidance offsets earnings beat

Israel’s attack on Iran spares oil, nuclear facilities and probably markets too

At Ross, ‘value offers’ worked, but discount retailer sounds cautious for the rest of the year

Norfolk Southern got more efficient in Q2 despite derailment settlement, shareholder fight

Tesla reports this week. The focus could shift ‘back to fundamentals’.

Monster Beverages’ stock is sinking. Executives are blaming convenience stores.

Off-price retailers could thrive, BofA says, citing this bullish data point

Ackman’s Pershing Square USA says IPO is still happening, despite NYSE delay notice

Related articles

Investors are bracing for higher-for-even-longer interest rates

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

Manufacturing activity surges in New York region to highest level in nearly three years

RFK Jr. would rattle health markets as head of HHS, but his confirmation is far from certain, analyst says

Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS

Powell says Fed doesn’t need to hurry to cut interest rates

Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug

Off-price retailers could thrive, BofA says, citing this bullish data point

Company

Follow us